Inventor · disambiguated record
Oliver Szolar
Also filed as: SZOLAR OLIVER
8 granted patents·13 pending applications·6 citations·filing 2012–2016
76Inventor score
Top patents by PatentIndex Score
21 records- 0178US9827244B2Cap/endo dual inhibitors and their use in the treatment, amelioration or prevention of a viral diseaseHOFFMANN LA ROCHE·Filed 2016·Granted Nov 28, 2017·3 cites·20 claims
- 0270US8921388B2Dihydroxypyrimidine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2013·Granted Dec 30, 2014·2 cites·28 claims
- 0363US9434745B27-oxo-thiazolopyridine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2013·Granted Sep 6, 2016·1 cites·14 claims
- 0462US9199987B2Substituted naphthyridines for the treatment, amelioration or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2014·Granted Dec 1, 2015·0 cites·8 claims
- 0558US9505758B2Substituted 1,5-naphthyridines as endonuclease inhibitorsSAVIRA PHARMACEUTICALS GMBH·Filed 2015·Granted Nov 29, 2016·0 cites·5 claims
- 0655US2017290834A1Naphthyridinone derivatives and their use in the treatment, amelioration or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2016·Application pending·0 cites
- 0751US2013102601A1Pyrimidin-4-one derivatives and their use in the treatment, amelioration or prevention of a viral diseaseHOFFMANN LA ROCHE·Filed 2012·Application pending·0 cites
- 0849US2013102600A1Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral diseaseHOFFMANN LA ROCHE·Filed 2012·Application pending·0 cites
- 0948US9359351B2Cap/endo dual inhibitors and their use in the treatment, amelioration or prevention of a viral diseaseHOFFMANN LA ROCHE·Filed 2015·Granted Jun 7, 2016·0 cites·19 claims
- 1047US2016362423A17-oxo-thiazolopyridine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2016·Application pending·0 cites
- 1143US8952039B2Pyridone derivatives and their use in the treatment, ameloriation or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2014·Granted Feb 10, 2015·0 cites·13 claims
- 1243US2013317021A1Heterocyclic pyrimidine carbonic acid derivatives which are useful in the treatment, amelioration or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2013·Application pending·0 cites
- 1342US9045486B2Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2014·Granted Jun 2, 2015·0 cites·13 claims
- 1442US2016297763A1Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral diseaseF HOFFMANN-LA ROCHE LTD·Filed 2016·Application pending·0 cites
- 1541US2017081323A1Triazolones derivatives for use in the treatment, amelioration or prevention of a viral diseaseHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 1641US2017081331A1Pyrazolopyrazines and their use in the treatment, amelioration or prevention of a viral diseaseHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 1738US2016367557A1Heterocyclic pyrimidine carbonic acid derivatives which are useful in the treatment, amelioration or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2016·Application pending·0 cites
- 1836US2017100396A1Pyrrolopyrazine derivatives for use in the treatment, amelioration or prevention of influenzaHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 1936US2016376286A1Pyrimidin-4-one derivatives and their use in the tratement, amelioration or prevention of a viral diseaseF HOFFMANN-LA ROCHE LTD·Filed 2016·Application pending·0 cites
- 2035US2017081324A1Triazolones derivatives and their use in the treatment, amelioration or prevention of a viral diseaseHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 2132US2016002226A1Pyridopyrazine compounds and their use in the treatment, amelioration or prevention of influenzaHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →